Onward Medical N.V. (ONWD.BR)
| Previous close | 4.92 |
| Open | 5.38 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 5.20 - 5.48 |
| 52-week range | 1.85 - 6.58 |
| Volume | |
| Avg. volume | 101,574 |
| Market cap | 186.996M |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.20 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.90 |
GlobeNewswireNature Medicine Highlights Significant Improvement in Hand and Arm Function After Spinal Cord Injury with Use of ONWARD® ARC-EX® Therapy
ARC Therapy™ shown to be safe and effective in global pivotal trial* 90% of participants improved either strength or function of upper limbs* Improvement demonstrated in participants up to 34 years post-injury* 87% of participants also reported improvement in overall quality of life* EINDHOVEN, the Netherlands, May 20, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function,
GlobeNewswireONWARD® Medical Schedules Webcast to Provide Q1 2024 Business Update
EINDHOVEN, the Netherlands, May 15, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces that it will host a webcast to discuss its Q1 2024 business highlights. The webcast will be held on May 23, 2024, at 2:30PM CET / 08:30AM ET. It will be hosted by CEO Dave Marver who will discuss highlights from
- GlobeNewswire
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
EINDHOVEN, the Netherlands, May 02, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today has convened the 2024 Annual General Meeting of Shareholders (AGM), which will include consideration of the resolutions to be submitted for adoption at the AGM, which will be held in Amsterdam, the Netherlands, on June 13,
